Join to View Full Profile
1420 Beverly RoadSte 300McLean, VA 22101
Phone+1 888-896-1400
Dr. Ailani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jessica Ailani is a neurologist in McLean, VA and is affiliated with MedStar Georgetown University Hospital. She received her medical degree from Stony Brook University School of Medicine and has been in practice 13 years. She specializes in headache and is experienced in headache medicine, migraine disorders, and botulinum toxin injections for headache.
Education & Training
NYU Grossman School of MedicineResidency, Neurology, 2005 - 2008
NYU Grossman Long Island School of MedicineInternship, Internal Medicine, 2004 - 2005
Stony Brook University Health Sciences Center School of MedicineClass of 2004
Certifications & Licensure
DC State Medical License 2009 - 2026
VA State Medical License 2010 - 2026
MD State Medical License 2015 - 2024
NY State Medical License 2005 - 2010
PA State Medical License 2008 - 2009
American Board of Psychiatry and Neurology Neurology
UCNSHeadache Medicine
Publications & Presentations
PubMed
- Effect of erenumab versus other migraine preventive medications on cardiovascular and cerebrovascular outcomes: A United States claims database-based observational coh...David W Dodick, Stewart J Tepper, Jessica Ailani, Ani C Khodavirdi, Nico Pannacciulli
Headache. 2025-03-03 - 1 citationsReduction of pain and functional disability over time in patients treated with zavegepant: a post-hoc analysis of the BHV3500-301 phase 3 randomized controlled trial.Lauren Powell, Fiona O'Sullivan, Pramoda Jayasinghe, Basia Rogula, Feng Dai
The Journal of Headache and Pain. 2025-01-02 - Long-Term (12-Month) Safety and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine: Data from the Phase 3 Open-Label ASCEND Study.Stewart J Tepper, Detlef Albrecht, Jessica Ailani, Louis Kirby, Shannon Strom
CNS Drugs. 2024-12-01
Authored Content
- AHS 2021: Sex and Gender-Specific Differences in HeadacheJune 2021
Press Mentions
Epidural Patching Outcomes and Predictors of Benefit in Patients with Suspected CSF LeakJuly 11th, 2024- New Guidance on CGRPs as First-Line Migraine Prevention: How/Will It Change Clinical Practice?June 20th, 2024
- First Intranasal CGRP Drug Is Approved, Offering Rapid-Onset… : Neurology TodayApril 6th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
